Skip to main navigation Skip to search Skip to main content

Gemcitabine-associated reversible encephalopathy a case report

  • Su Gülsün Berrak
  • , Ahmet Soysal
  • , Emine Türkkan
  • , Cengiz Canpolat

Research output: Contribution to journal › Article › peer-review

Abstract

In this report, we present a ten-year-old male patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.

Original languageEnglish (US)
Pages (from-to)180-182
Number of pages3
JournalMarmara Medical Journal
Volume15
Issue number3
StatePublished - Jul 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gemcitabine
  • Neurotoxicity
  • Pediatric cancer

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Gemcitabine-associated reversible encephalopathy a case report'. Together they form a unique fingerprint.

Cite this